Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2009 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for paroxetine la sant
Your search for paroxetina-la-sant retrieved no results
[Treatment of non cognitive symptoms of Alzheimer's disease].
Grau-Veciana JM. Grau-Veciana JM. Rev Neurol. 2006 Apr 16-30;42(8):482-8. Rev Neurol. 2006. PMID: 16625511 Free article. Review. Spanish.
The good tolerance and absence of anticholinergic effects of the serotonin reuptake inhibitors, fluoxetin and paroxetine, make them the first-choice medication for the treatment of the depressive symptoms in AD. ...
The good tolerance and absence of anticholinergic effects of the serotonin reuptake inhibitors, fluoxetin and paroxetine, make them t …
Pindolol augmentation enhances response outcomes in first depressive episodes.
Portella MJ, de Diego-Adeliño J, Puigdemont D, Pérez-Egea R, Alvarez E, Artigas F, Pérez V. Portella MJ, et al. Eur Neuropsychopharmacol. 2009 Jul;19(7):516-9. doi: 10.1016/j.euroneuro.2009.04.004. Epub 2009 May 5. Eur Neuropsychopharmacol. 2009. PMID: 19419845 Clinical Trial.
., Stelzig, R., Stuppaeck, C., Bondy, B. and Aichhorn, W. (2008) Paroxetine with Pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. ...Neuropsychopharmacol. 18, 141-146.] have found that never-medicated depressed patients …
., Stelzig, R., Stuppaeck, C., Bondy, B. and Aichhorn, W. (2008) Paroxetine with Pindolol augmentation: a double-blind, randomized, p …
Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ, Clos S, Romero S, Morte A, Giménez S, Lorenzo JL, Luque A, Dal-Ré R. Barbanoj MJ, et al. Neuropsychobiology. 2005;51(3):134-47. doi: 10.1159/000085206. Epub 2005 Apr 18. Neuropsychobiology. 2005. PMID: 15838185 Clinical Trial.
AIMS: To evaluate the potential interaction of 20 mg paroxetine and 1 mg alprazolam (early morning once-daily administration) on polysomnographic (PSG) sleep and subjective sleep and awakening quality, both after a single intake and after reaching a steady-state concentrat …
AIMS: To evaluate the potential interaction of 20 mg paroxetine and 1 mg alprazolam (early morning once-daily administration) on poly …
Postpartum depression without delivering a child?
Manfredi G, Lazanio S, Kotzalidis GD, Ruberto A, Girardi P, Tatarelli R. Manfredi G, et al. Acta Psychiatr Scand. 2005 Sep;112(3):233-6; discussion 236-7. doi: 10.1111/j.1600-0447.2005.00560.x. Acta Psychiatr Scand. 2005. PMID: 16095479